Haoxi Health Technology Limited (HAO) Fair Value 2026

HAO · Advertising Agencies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

2.5 /10

32 fundamental signals · 0 models active

Value Trap Risk

SAFE (0/100)

Quick Summary — As of 2026-08-28, Haoxi Health Technology Limited (HAO) trades at $3.07. QOC: 2.5/10. Value Trap Risk: 0/100 (SAFE). 0/13 models active.

Key Facts

Ticker
HAO
Price
$3.07
Quality Score
2.5/10
Value Trap Risk
0/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 2.5/10 signals weak fundamentals

What Fair Value Does Each Model Give HAO?

0 Intrinsic Value Models vs. Current Price ($3.07)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Haoxi Health Technology Limited (HAO) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Haoxi Health Technology Limited currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About HAO?

0 of 13 models are currently active for HAO. See which stocks rank higher →

How Does HAO Rank in Advertising Agencies?

Among 48 Advertising Agencies stocks, HAO ranks #46 by Quality of Company score. CirclFi's QOC score of 2.5/10 evaluates 32 fundamental signals. A score of 2.5 signals below-average fundamentals.

Haoxi Health Technology Limited operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is HAO a Value Trap?

CirclFi's Value Trap algorithm assigns HAO a score of 0/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Haoxi Health Technology Limited. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Haoxi Health Technology Limited scores 2.5 out of 10 on our 32-signal quality assessment, a weak rating that exhibits fundamental weaknesses that warrant careful scrutiny. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every HAO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Haoxi Health Technology Limited Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Advertising Agencies Stocks Should You Also Analyze?

10 related Advertising Agencies stocks with 13-model coverage

BAOSBaosheng Media Group Holdings LimitedQOC 2.5NEXNNexxen International Ltd.QOC 2.3EDHLEverbright Digital Holding LimitedQOC 2.9YDKGYueda Digital HoldingQOC 2.3MOBQMobiquity Technologies, Inc.QOC 3.9APPAppLovin CorporationQOC 9.5CHRCheer Holding, Inc.QOC 7.6TDICDreamland LimitedQOC 5.9LFTOLiftoff Mobile, Inc.QOC 4.9QNSTQuinStreet, Inc.QOC 9.0

Read investment analysis: BAOS · NEXN · EDHL · YDKG · MOBQ · APP · CHR · TDIC · LFTO · QNST

Which Other Stocks Have a Similar Quality Score to HAO?

7 companies across all industries closest to HAO’s Quality of Company score of 2.5/10.

GMEXGMEX Robotics CorporationQOC 2.5CLPSCLPS IncorporationQOC 2.5MBAICheck-Cap Ltd.QOC 2.5BANLCBL International LimitedQOC 2.5OTLYOatly Group ABQOC 2.5CANFCan-Fite BioPharma Ltd.QOC 2.5NVDANVIDIA CorporationQOC 10.0

Read investment analysis: GMEX · CLPS · MBAI · BANL · OTLY · CANF · NVDA

What Else Do Investors Ask About Haoxi Health Technology Limited’s Valuation?

What is Haoxi Health Technology Limited's intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Haoxi Health Technology Limited (HAO). The Quality of Company score is 2.5/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is HAO overvalued or undervalued right now?

At $3.07, 0 of 0 active models suggest HAO may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Haoxi Health Technology Limited's business model in Advertising Agencies.

What does a Quality of Company score of 2.5 mean for HAO?

Haoxi Health Technology Limited's QOC of 2.5/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on HAO?

CirclFi analyzes HAO with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is HAO a value trap in 2026?

Haoxi Health Technology Limited's Value Trap score is 0/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Haoxi Health Technology Limited (HAO) a Quality of Company score of 2.5/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/HAO/ · Methodology
Primary sources for this HAO valuation
  • Financial statements: Haoxi Health Technology Limited 10-K and 10-Q filings on SEC EDGAR (CIK 0001954594) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for HAO as of ; valuations recomputed .